Materials for the first ad-hoc shareholders' meeting in 2024.
Announcement Regarding the Delay of Some Capex Projects.
Notice of the First Extraordinary Shareholders' Meeting in 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Shanghai Tongli Law Firm on the 2023 Annual General Meeting of Shareholders of Jiangsu Kangwei Century Biotechnology Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Notice on Voluntary Disclosure of Wholly-owned Subsidiary Products Obtaining Three Types of Medical Device Registration Certificates
Report of the Board of Auditors on the performance of supervisory duties by accounting firms
Announcement on preparation for impairment of assets accrued in 2023
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Announcement on changing the registered capital and amending the “Articles of Association”
Notice on Continuing to Use Temporarily Idle Own Funds for Cash Management
Notice on convening the 2023 Annual General Meeting of Shareholders
2023 Internal Control Evaluation Report
2023 Performance Report of the Audit Committee of the Board
Special report of the board of directors on the self-inspection of the independence of independent directors
Report on the evaluation of the accounting firm's performance
Announcement of Resolutions of the Fourth Extraordinary General Meeting of Shareholders in 2023
Legal Opinion of Shanghai Tongli Law Firm on the 2023 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Kangwei Century Biotechnology Co., Ltd.
Materials of the 2023 Fourth Extraordinary General Meeting of Shareholders
No Data